Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (797)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 591 to 600 of 797
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
TA395
22 June 2016
22 June 2016
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma
TA396
22 June 2016
22 June 2016
Adalimumab for treating moderate to severe hidradenitis suppurativa
TA392
22 June 2016
22 June 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
TA390
25 May 2016
25 May 2016
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
TA388
27 April 2016
27 April 2016
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
TA389
27 April 2016
27 April 2016
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
TA386
23 March 2016
23 March 2016
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
TA23
26 April 2001
3 March 2016
Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia
TA385
24 February 2016
24 February 2016
Nivolumab for treating advanced (unresectable or metastatic) melanoma
TA384
18 February 2016
18 February 2016
Previous page
1
…
58
59
Current page
60
61
62
…
80
Page
60
of
80
Next page
Results per page
10
25
50
All
Back to top